COVIVIO HOTELS SACA (COVH.PA) Fundamental Analysis & Valuation

EPA:COVH • FR0000060303

Current stock price

24.2 EUR
+0.3 (+1.26%)
Last:

This COVH.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. COVH.PA Profitability Analysis

1.1 Basic Checks

  • COVH had positive earnings in the past year.
  • In the past year COVH had a positive cash flow from operations.
  • COVH had positive earnings in 4 of the past 5 years.
  • COVH had a positive operating cash flow in each of the past 5 years.
COVH.PA Yearly Net Income VS EBIT VS OCF VS FCFCOVH.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M 400M

1.2 Ratios

  • COVH's Return On Assets of 4.53% is fine compared to the rest of the industry. COVH outperforms 66.67% of its industry peers.
  • With a decent Return On Equity value of 8.34%, COVH is doing good in the industry, outperforming 66.67% of the companies in the same industry.
  • COVH has a Return On Invested Capital (3.47%) which is in line with its industry peers.
  • COVH had an Average Return On Invested Capital over the past 3 years of 3.84%. This is in line with the industry average of 3.75%.
Industry RankSector Rank
ROA 4.53%
ROE 8.34%
ROIC 3.47%
ROA(3y)2.5%
ROA(5y)3.01%
ROE(3y)4.84%
ROE(5y)5.9%
ROIC(3y)3.84%
ROIC(5y)3.38%
COVH.PA Yearly ROA, ROE, ROICCOVH.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 -5 10 -10

1.3 Margins

  • COVH has a Profit Margin (43.94%) which is comparable to the rest of the industry.
  • In the last couple of years the Profit Margin of COVH has declined.
  • COVH has a Operating Margin of 36.53%. This is in the lower half of the industry: COVH underperforms 71.43% of its industry peers.
  • COVH's Operating Margin has declined in the last couple of years.
  • The Gross Margin of COVH (52.00%) is worse than 73.81% of its industry peers.
  • COVH's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 36.53%
PM (TTM) 43.94%
GM 52%
OM growth 3Y-30.11%
OM growth 5Y-7.29%
PM growth 3Y-39.31%
PM growth 5YN/A
GM growth 3Y15.72%
GM growth 5Y8.73%
COVH.PA Yearly Profit, Operating, Gross MarginsCOVH.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100 -100 -200

5

2. COVH.PA Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), COVH is destroying value.
  • COVH has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, COVH has more shares outstanding
  • Compared to 1 year ago, COVH has an improved debt to assets ratio.
COVH.PA Yearly Shares OutstandingCOVH.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M
COVH.PA Yearly Total Debt VS Total AssetsCOVH.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

2.2 Solvency

  • COVH has an Altman-Z score of 1.30. This is a bad value and indicates that COVH is not financially healthy and even has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of 1.30, COVH is in the better half of the industry, outperforming 78.57% of the companies in the same industry.
  • The Debt to FCF ratio of COVH is 9.89, which is on the high side as it means it would take COVH, 9.89 years of fcf income to pay off all of its debts.
  • With an excellent Debt to FCF ratio value of 9.89, COVH belongs to the best of the industry, outperforming 80.95% of the companies in the same industry.
  • COVH has a Debt/Equity ratio of 0.67. This is a neutral value indicating COVH is somewhat dependend on debt financing.
  • With a Debt to Equity ratio value of 0.67, COVH perfoms like the industry average, outperforming 54.76% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.67
Debt/FCF 9.89
Altman-Z 1.3
ROIC/WACC0.64
WACC5.43%
COVH.PA Yearly LT Debt VS Equity VS FCFCOVH.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B 2B 3B

2.3 Liquidity

  • A Current Ratio of 1.81 indicates that COVH should not have too much problems paying its short term obligations.
  • With an excellent Current ratio value of 1.81, COVH belongs to the best of the industry, outperforming 92.86% of the companies in the same industry.
  • COVH has a Quick Ratio of 1.80. This is a normal value and indicates that COVH is financially healthy and should not expect problems in meeting its short term obligations.
  • With an excellent Quick ratio value of 1.80, COVH belongs to the best of the industry, outperforming 95.24% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.81
Quick Ratio 1.8
COVH.PA Yearly Current Assets VS Current LiabilitesCOVH.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

4

3. COVH.PA Growth Analysis

3.1 Past

  • COVH shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 30.73%, which is quite impressive.
  • The earnings per share for COVH have been decreasing by -14.88% on average. This is quite bad
  • Looking at the last year, COVH shows a very strong growth in Revenue. The Revenue has grown by 53.70%.
  • COVH shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 35.44% yearly.
EPS 1Y (TTM)30.73%
EPS 3Y-14.88%
EPS 5YN/A
EPS Q2Q%98.41%
Revenue 1Y (TTM)53.7%
Revenue growth 3Y42.19%
Revenue growth 5Y35.44%
Sales Q2Q%12.3%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-1.17%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year2.33%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
COVH.PA Yearly Revenue VS EstimatesCOVH.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 200M 400M 600M
COVH.PA Yearly EPS VS EstimatesCOVH.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 0.5 1 1.5

3

4. COVH.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 12.22 indicates a correct valuation of COVH.
  • The rest of the industry has a similar Price/Earnings ratio as COVH.
  • Compared to an average S&P500 Price/Earnings ratio of 26.86, COVH is valued rather cheaply.
  • The Price/Forward Earnings ratio is 14.04, which indicates a correct valuation of COVH.
  • Based on the Price/Forward Earnings ratio, COVH is valued a bit more expensive than the industry average as 69.05% of the companies are valued more cheaply.
  • The average S&P500 Price/Forward Earnings ratio is at 37.39. COVH is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 12.22
Fwd PE 14.04
COVH.PA Price Earnings VS Forward Price EarningsCOVH.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of COVH is on the same level as its industry peers.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of COVH is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 14.83
EV/EBITDA 17.83
COVH.PA Per share dataCOVH.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

7

5. COVH.PA Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 6.28%, COVH is a good candidate for dividend investing.
  • COVH's Dividend Yield is a higher than the industry average which is at 5.18.
  • COVH's Dividend Yield is rather good when compared to the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 6.28%

5.2 History

  • The dividend of COVH is nicely growing with an annual growth rate of 64.76%!
Dividend Growth(5Y)64.76%
Div Incr Years4
Div Non Decr Years5
COVH.PA Yearly Dividends per shareCOVH.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 2026 1 2 3

5.3 Sustainability

  • 12.80% of the earnings are spent on dividend by COVH. This is a low number and sustainable payout ratio.
DP12.8%
EPS Next 2YN/A
EPS Next 3YN/A
COVH.PA Yearly Income VS Free CF VS DividendCOVH.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M 400M
COVH.PA Dividend Payout.COVH.PA Dividend Payout, showing the Payout Ratio.COVH.PA Dividend Payout.PayoutRetained Earnings

COVH.PA Fundamentals: All Metrics, Ratios and Statistics

COVIVIO HOTELS SACA

EPA:COVH (4/10/2026, 7:00:00 PM)

24.2

+0.3 (+1.26%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)02-18
Earnings (Next)07-21
Inst Owners31.73%
Inst Owner ChangeN/A
Ins Owners0%
Ins Owner ChangeN/A
Market Cap3.82B
Revenue(TTM)700.20M
Net Income(TTM)307.70M
Analysts82.86
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 6.28%
Yearly Dividend0.26
Dividend Growth(5Y)64.76%
DP12.8%
Div Incr Years4
Div Non Decr Years5
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 12.22
Fwd PE 14.04
P/S 5.46
P/FCF 14.83
P/OCF 12.29
P/B 1.04
P/tB 1.14
EV/EBITDA 17.83
EPS(TTM)1.98
EY8.18%
EPS(NY)1.72
Fwd EY7.12%
FCF(TTM)1.63
FCFY6.74%
OCF(TTM)1.97
OCFY8.14%
SpS4.43
BVpS23.36
TBVpS21.31
PEG (NY)N/A
PEG (5Y)N/A
Graham Number32.26
Profitability
Industry RankSector Rank
ROA 4.53%
ROE 8.34%
ROCE 3.92%
ROIC 3.47%
ROICexc 3.51%
ROICexgc 3.69%
OM 36.53%
PM (TTM) 43.94%
GM 52%
FCFM 36.82%
ROA(3y)2.5%
ROA(5y)3.01%
ROE(3y)4.84%
ROE(5y)5.9%
ROIC(3y)3.84%
ROIC(5y)3.38%
ROICexc(3y)4.06%
ROICexc(5y)3.53%
ROICexgc(3y)4.24%
ROICexgc(5y)3.66%
ROCE(3y)4.33%
ROCE(5y)3.81%
ROICexgc growth 3Y1.88%
ROICexgc growth 5Y26.81%
ROICexc growth 3Y0.7%
ROICexc growth 5Y25.99%
OM growth 3Y-30.11%
OM growth 5Y-7.29%
PM growth 3Y-39.31%
PM growth 5YN/A
GM growth 3Y15.72%
GM growth 5Y8.73%
F-Score7
Asset Turnover0.1
Health
Industry RankSector Rank
Debt/Equity 0.67
Debt/FCF 9.89
Debt/EBITDA 6.96
Cap/Depr 54.77%
Cap/Sales 7.63%
Interest Coverage 4.26
Cash Conversion 88.08%
Profit Quality 83.78%
Current Ratio 1.81
Quick Ratio 1.8
Altman-Z 1.3
F-Score7
WACC5.43%
ROIC/WACC0.64
Cap/Depr(3y)125.87%
Cap/Depr(5y)134.29%
Cap/Sales(3y)12.4%
Cap/Sales(5y)21.3%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)30.73%
EPS 3Y-14.88%
EPS 5YN/A
EPS Q2Q%98.41%
EPS Next Y-1.17%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)53.7%
Revenue growth 3Y42.19%
Revenue growth 5Y35.44%
Sales Q2Q%12.3%
Revenue Next Year2.33%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-11.12%
EBIT growth 3Y-0.62%
EBIT growth 5Y25.57%
EBIT Next Year-5.42%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y21.09%
FCF growth 3Y11.53%
FCF growth 5Y55.72%
OCF growth 1Y-10.63%
OCF growth 3Y6.6%
OCF growth 5Y31.01%

COVIVIO HOTELS SACA / COVH.PA Fundamental Analysis FAQ

What is the fundamental rating for COVH stock?

ChartMill assigns a fundamental rating of 4 / 10 to COVH.PA.


What is the valuation status for COVH stock?

ChartMill assigns a valuation rating of 3 / 10 to COVIVIO HOTELS SACA (COVH.PA). This can be considered as Overvalued.


Can you provide the profitability details for COVIVIO HOTELS SACA?

COVIVIO HOTELS SACA (COVH.PA) has a profitability rating of 4 / 10.


What is the valuation of COVIVIO HOTELS SACA based on its PE and PB ratios?

The Price/Earnings (PE) ratio for COVIVIO HOTELS SACA (COVH.PA) is 12.22 and the Price/Book (PB) ratio is 1.04.


Can you provide the dividend sustainability for COVH stock?

The dividend rating of COVIVIO HOTELS SACA (COVH.PA) is 7 / 10 and the dividend payout ratio is 12.8%.